These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide. Mogelvang R; Goetze JP; Schnohr P; Lange P; Sogaard P; Rehfeld JF; Jensen JS J Am Coll Cardiol; 2007 Oct; 50(17):1694-701. PubMed ID: 17950153 [TBL] [Abstract][Full Text] [Related]
3. B-type natriuretic peptides and the general practitioner. Mueller C J Am Coll Cardiol; 2007 Oct; 50(17):1702-3. PubMed ID: 17950154 [No Abstract] [Full Text] [Related]
6. B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children. Maher KO; Reed H; Cuadrado A; Simsic J; Mahle WT; Deguzman M; Leong T; Bandyopadhyay S Pediatrics; 2008 Jun; 121(6):e1484-8. PubMed ID: 18519452 [TBL] [Abstract][Full Text] [Related]
7. N-terminal pro A-type natriuretic peptide but not N-terminal pro C-type natriuretic peptide concentrations are related to cardiac diseases in infants. Hammerer-Lercher A; Puschendorf B; Sommer R; Mair J; Tulzer G; Lechner E; Hawa G; Maitzen S; Woloszczuk W Clin Chim Acta; 2008 May; 391(1-2):118-9. PubMed ID: 18280250 [No Abstract] [Full Text] [Related]
8. Acute transient leukopenia as a sign of TRALI. Marques MB; Tuncer HH; Divers SG; Baker AC; Harrison DK Am J Hematol; 2005 Sep; 80(1):90-1. PubMed ID: 16138350 [No Abstract] [Full Text] [Related]
9. The clinical value of rapid assay for plasma B-type natriuretic peptide in differentiating congestive heart failure from pulmonary causes of dyspnoea. Zhao SQ; Hu YM; Li Q; Liu XR; Wang M; Zhang WY; Wu T; Nie XL; Zhao N; Wang LR Int J Clin Pract; 2008 Feb; 62(2):214-20. PubMed ID: 18081799 [TBL] [Abstract][Full Text] [Related]
15. Acute lung injury after ruptured abdominal aortic aneurysm repair: the effect of excluding donations from females from the production of fresh frozen plasma. Wright SE; Snowden CP; Athey SC; Leaver AA; Clarkson JM; Chapman CE; Roberts DR; Wallis JP Crit Care Med; 2008 Jun; 36(6):1796-802. PubMed ID: 18496377 [TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload. Tobian AA; Sokoll LJ; Tisch DJ; Ness PM; Shan H Transfusion; 2008 Jun; 48(6):1143-50. PubMed ID: 18298592 [TBL] [Abstract][Full Text] [Related]
17. Plasma brain natriuretic peptide correlates with infarct size but not with subsequent remodeling in the rat heart. Maczewski M; Mackiewicz U Cardiovasc Pathol; 2007; 16(2):79-84. PubMed ID: 17317540 [TBL] [Abstract][Full Text] [Related]
18. Brain natriuretic peptide in heart failure and beyond. Mowla MM; Bustami BB Saudi Med J; 2006 Oct; 27(10):1457-61. PubMed ID: 17013463 [TBL] [Abstract][Full Text] [Related]
19. Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study. Christ M; Laule-Kilian K; Hochholzer W; Klima T; Breidthardt T; Perruchoud AP; Mueller C J Am Coll Cardiol; 2006 Nov; 48(9):1808-12. PubMed ID: 17084254 [TBL] [Abstract][Full Text] [Related]
20. Plasma B-type natriuretic peptide for early diagnosis of allograft rejection after renal transplantation. Sun TW; Zhang SY; Wang LX Med Hypotheses; 2008; 70(6):1160-2. PubMed ID: 18191909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]